Aspirin-Exacerbated Respiratory Disease: Prevalence, Diagnosis, Treatment, and Considerations for the Future
- 1 November 2016
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 30 (6) , 407-413
Abstract
Aspirin-exacerbated respiratory disease (AERD) is a late onset condition characterized by the Samter triad (aspirin sensitivity [as well as sensitivity to any nonselective cyclooxygenase inhibitor], nasal polyps, asthma) and additional features, including eosinophilic chronic rhinosinusitis, hypereosinophilia, anosmia, frequent absence of atopy, and, intolerance to ingestion of red wine and other alcoholic beverages. The diagnosis is rare, and, because of this, it is also often missed by physicians. However, it is highly overexpressed in patients with severe asthma (and severe chronic rhinosinusitis with nasal polyps), which makes its recognition essential. For this review, we considered mechanisms involved in the pathogenesis of this disease and discussed the clinical symptoms of AERD. We also discussed the role of aspirin desensitization in the treatment of AERD. Also, we considered medications (e.g, leukotriene modifiers) and surgical interventions that have a role in the treatment of AERD.Keywords
This publication has 90 references indexed in Scilit:
- Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter RegistryJournal of Asthma, 2013
- Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytesBlood, 2012
- Niacin and biosynthesis of PGD2 by platelet COX-1 in mice and humansJournal of Clinical Investigation, 2012
- Long-term benefits of omalizumab in a patient with severe non-allergic asthmaAllergy, Asthma & Clinical Immunology, 2011
- Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptorJournal of Experimental Medicine, 2009
- Functional recognition of a distinct receptor preferential for leukotriene E4in mice lacking the cysteinyl leukotriene 1 and 2 receptorsProceedings of the National Academy of Sciences, 2008
- Expression of 5‐lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin‐intolerant asthmaThe Journal of Pathology, 2006
- Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory diseaseAnnals of Allergy, Asthma & Immunology, 2005
- Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmaticsAnnals of Allergy, Asthma & Immunology, 2000
- Concerning the nature of intolerance to aspirinJournal of Allergy, 1967